Myeloma

March 23, 2023

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma
December 15, 2021

Now Enrolling: The OPTIMUM clinical trial is studying an additional treatment for patients with multiple myeloma

This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant